PolyNovo Limited (ASX: PNV)
Australia
· Delayed Price · Currency is AUD
1.990
-0.040 (-1.97%)
Nov 21, 2024, 4:10 PM AEST
PolyNovo Revenue
In the fiscal year ending June 30, 2024, PolyNovo had annual revenue of 103.23M AUD with 57.20% growth. PolyNovo had revenue of 56.04M in the half year ending June 30, 2024, with 136.11% growth.
Revenue
103.23M
Revenue Growth
+57.20%
P/S Ratio
13.31
Revenue / Employee
406.41K
Employees
254
Market Cap
1.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 103.23M | 37.56M | 57.20% |
Jun 30, 2023 | 65.67M | 23.78M | 56.76% |
Jun 30, 2022 | 41.89M | 12.55M | 42.78% |
Jun 30, 2021 | 29.34M | 7.15M | 32.19% |
Jun 30, 2020 | 22.19M | 8.15M | 58.03% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |
PolyNovo News
- 3 months ago - Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and ... - GuruFocus